MedTrace Logo

Efficacy of GONB in Patients of Migraine

NCT05679765 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-01-12

No results posted yet for this study

Summary

The study was carried to determine the analgesic efficacy of greater occipital nerve block in patients of migraine. It was a randomised controlled which took place from april 2022 - october 2022. Fifty patients suffering from migraine were included in the study. Patients in Group G were given greater occipital nerve block (GONB) with lignocaine and dexamethasone under ultrasound guidance while those in Group S were given saline 0.9% as placebo. Pain score using Numeric Rating Scale and number of headache days was assessed at four,eight and twelve weeks after the procedure as a primary outcome. Total headache days were recorded as a secondary outcome.

Conditions

Interventions

DRUG

Greater Occipital Nerve Block with dexamethasone and lidocaine

Ultrasound guided Greater occipital nerve block on the side of headache

DRUG

Greater Occipital Nerve Block with 0.9% saline

Ultrasound guided Greater occipital nerve block on the side of headache

Sponsors & Collaborators

  • Pain Medicine Department

    lead OTHER

Principal Investigators

  • Moazzam Ali · Pain Medicine Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05679765 on ClinicalTrials.gov